The American College of Radiology (ACR) provided the White House with recommendations on regulating and monitoring AI technologies in clinical radiology.
Key Details
- 1ACR submitted feedback to the White House Office of Science and Technology Policy on AI integration in clinical settings.
- 2Key focus areas include AI oversight, reimbursement strategies, and government transparency.
- 3ACR stressed enhancing FDA oversight, especially for adaptive and continuous learning AI systems.
- 4They recommended real-world and post-market monitoring to address issues like AI model drift.
- 5ACR highlighted national AI registries such as Assess-AI for ongoing model performance tracking and data privacy concerns.
Why It Matters
These recommendations will help shape national policy around safe, effective, and transparent use of AI in radiology, directly impacting radiologists, vendors, and patients. Real-world tracking and better regulation are critical for trustworthy AI adoption in medical imaging.
Source
Radiology Business
Related News
•Radiology Business
FDA-Cleared Imaging AI Proliferates, But Reimbursement Stalls
Despite a surge in FDA-cleared radiology AI tools, very few qualify for reimbursement due to lack of supporting clinical studies.
•HealthExec
Lawsuit Alleges AI Note-Taking Tool Secretly Recorded Patient Exams
Sharp HealthCare faces a lawsuit for allegedly using AI to record patient-clinician conversations without consent.
•HealthExec
US Executive Order and HHS Strategy Set AI Policy Directions for Healthcare
The White House executive order and new HHS strategy shift US policy towards unified AI standards and expanded adoption in healthcare.